miR-148a-3p overexpression contributes to glomerular cell proliferation by targeting PTEN in lupus nephritis

Liu Qingjuan1, Feng Xiaojuan1, Zhang Wei1

  • 1Department of Pathology, Hebei Medical University, Key Laboratory of Kidney Diseases of Hebei Province, Shijiazhuang, China;

Insights

MicroRNA-148a-3p is elevated in lupus nephritis (LN) and promotes glomerular cell proliferation by targeting PTEN. Reducing miR-148a-3p expression may improve renal function in LN patients.

Area of Science:

  • Nephrology
  • Molecular Biology
  • Immunology

Background:

  • Lupus nephritis (LN) is a severe complication of systemic lupus erythematosus.
  • The role of microRNAs (miRNAs) in the pathogenesis of LN is increasingly recognized.
  • miR-148a-3p has been implicated in various cellular processes, but its specific role in LN remains unclear.

Purpose of the Study:

  • To investigate the expression and function of miR-148a-3p in lupus nephritis.
  • To determine the clinicopathological significance of miR-148a-3p in LN.
  • To elucidate the molecular mechanisms underlying miR-148a-3p's effect on glomerular cell proliferation and LN progression.

Main Methods:

  • MicroRNA expression profiling in LN renal tissues and serum.
  • In vitro and in vivo functional assays of miR-148a-3p.
  • Analysis of cell proliferation markers (PCNA) and signaling pathways (Akt/cyclin D1).
  • Target gene identification using luciferase assays and expression analysis (PTEN).

Main Results:

  • miR-148a-3p expression was significantly upregulated in glomeruli and serum of LN patients and mice.
  • Overexpression of miR-148a-3p enhanced glomerular cell proliferation and PCNA expression.
  • miR-148a-3p targeted and downregulated PTEN expression, a key regulator of cell proliferation.
  • Inhibition of miR-148a-3p or overexpression of PTEN suppressed cell proliferation and improved renal function in LN models.

Conclusions:

  • miR-148a-3p acts as a pro-proliferative factor in lupus nephritis.
  • The miR-148a-3p/PTEN axis plays a critical role in LN pathogenesis.
  • Targeting miR-148a-3p represents a potential therapeutic strategy for lupus nephritis.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.3K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K